Results
21,632 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Nguyen DianeEVP, Chief Legal Officer & GC |  QBTSD-Wave Quantum Inc.Open-market sale · 10b5-1 plan | SELL | $127K 4,519 sh | Jan 15, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Nguyen DianeEVP, Chief Legal Officer & GC | QBTSD-Wave Quantum Inc. Open-market sale · 10b5-1 plan | SELL | $127K 4,519 sh | Jan 15, 2026 |
| 4 |  Dines DanielDirector, CEO and Chairman, 10% Owner |  PATHUiPath, Inc.Open-market sale · 10b5-1 plan | SELL | $692K 45.0K sh | Jan 15, 2026 traded Jan 15, 2026 |
| 4 | Merriman Dwight ADirector |  MDBMongoDB, Inc.Open-market sale · 10b5-1 plan | SELL | $442K 1,139 sh | Jan 15, 2026 traded Jan 15, 2026 |
| 4 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $81K 200 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 4 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $139K 340 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 3 |  Farquhar ScottDirector, 10% Owner |  TEAMAtlassian CorpOpen-market sale · 10b5-1 plan | SELL | $41K 300 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $41K 300 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 2 | Bentley Sheldon Richard10% Owner, Founder |  CSAICLOUDASTRUCTURE, INC.Open-market sale · 10b5-1 plan | SELL | $22K 25.0K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 2 | Bentley Sheldon Richard10% Owner, Founder | CSAICLOUDASTRUCTURE, INC. Open-market sale · 10b5-1 plan | SELL | $21K 25.0K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 49 | Hildebrandt John DPresident and COO |  PSMTPRICESMART INCOpen-market sale | SELL | $1.02M 7,421 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 46 | Infante Beatriz VDirector | PSMTPRICESMART INC Open-market sale | SELL | $273K 1,995 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 46 | Kovaleski PaulEVP-Chief Merch. Officer | PSMTPRICESMART INC Open-market sale | SELL | $582K 4,255 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 44 | Brumana RodrigoChief Financial Officer |  JOBYJoby Aviation, Inc.Open-market sale | SELL | $7,756 523 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 43 | Duffy Sean P.Director, Chief Executive Officer |  OMDAOmada Health, Inc.Open-market sale | SELL | $1.45M 90.5K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 43 | Duffy Sean P.Director, Chief Executive Officer | OMDAOmada Health, Inc. Open-market sale | SELL | $2.15M 140.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 40 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF |  OLMAOlema Pharmaceuticals, Inc.Open-market sale | SELL | $1.37M 49.8K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale | SELL | $63K 170 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Bricker JudeDirector, Chief Executive Officer |  SNCYSun Country Airlines Holdings, Inc.Open-market sale | SELL | $89K 5,062 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 156 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $63K 176 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $133K 365 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $148K 405 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $65K 181 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector | PSMTPRICESMART INC Open-market sale | SELL | $205K 1,499 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Frank MalcolmDirector |  FDSFACTSET RESEARCH SYSTEMS INCOpen-market sale | SELL | $452K 1,527 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $102K 284 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector | PSMTPRICESMART INC Open-market sale | SELL | $207K 1,501 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $81K 226 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 38 | Allison EricChief Product Officer | JOBYJoby Aviation, Inc. Open-market sale | SELL | $319K 21.5K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $1.01M 35.0K sh | Jan 14, 2026 traded Jan 14, 2026 |
| 37 | Soule Randy10% Owner |  SAFXXCF Global, Inc.Open-market sale | SELL | $34K 200.0K sh | Jan 14, 2026 traded Jan 8, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $283K 10.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $35K 98 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |